Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Friday, 19 May 2017

EU Commission: Investment Plan for Europe: EIB grants financing to Biofrontera

Investment Plan for Europe: EIB grants financing to Biofrontera

The EIB will grant financing of up to EUR 20 million to the German biopharmaceutical company Biofrontera AG. The loan agreement has been signed today in Luxemburg. EUR 10m will be available for disbursement from signature, and further installments will be disbursed based on pre-defined commercial and regulatory milestones. EIB's transaction with Biofrontera was made possible by the support of the "European Fund for Strategic Investments" (EFSI). EFSI is the central pillar of the "Investment Plan for Europe", in which EIB Group and the European Commission are strategic partners.

Read more

EMA recommends changes to prescribing information for vancomycin antibiotics

Changes aim to ensure appropriate use in context of fight against antimicrobial resistance

Read more

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 May 2017

Eleven medicines recommended for approval, including one advanced therapy medicine

Read more

New advanced therapy to repair cartilage defects in the knee

Spherox recommended for marketing authorisation

Read more

New medicine for rare eye disease

Oxervate reviewed under accelerated assessment

Read more